Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial - Thiele, H; Wöhrle, J; Hambrecht, R (Lancet, 2012)
(9819):